Related Experiment Video
Updated: Jun 16, 2026

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
Betacellulin inhibits osteogenic differentiation and stimulates proliferation through HIF-1alpha
Damian C Genetos1, Rameshwar R Rao, Martin A Vidal
1Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California at Davis, 2112 Tupper Hall, Davis, CA 95616, USA. dgenetos@ucdavis.edu
Abstract:
Cellular signaling via epidermal growth factor (EGF) and EGF-like ligands can determine cell fate and behavior. Osteoblasts, which are responsible for forming and mineralizing osteoid, express EGF receptors and alter rates of proliferation and differentiation in response to EGF receptor activation. Transgenic mice over-expressing the EGF-like ligand betacellulin (BTC) exhibit increased cortical bone deposition; however, because the transgene is ubiquitously expressed in these mice, the identity of cells affected by BTC and responsible for increased cortical bone thickness remains unknown. We have therefore examined the influence of BTC upon mesenchymal stem cell (MSC) and pre-osteoblast differentiation and proliferation. BTC decreases the expression of osteogenic markers in both MSCs and pre-osteoblasts; interestingly, increases in proliferation require hypoxia-inducible factor-alpha (HIF-alpha), as an HIF antagonist prevents BTC-driven proliferation. Both MSCs and pre-osteoblasts express EGF receptors ErbB1, ErbB2, and ErbB3, with no change in expression under osteogenic differentiation. These are the first data that demonstrate an influence of BTC upon MSCs and the first to implicate HIF-alpha in BTC-mediated proliferation.
Insights
Betacellulin (BTC) impacts bone cell development by reducing osteogenic markers in mesenchymal stem cells (MSCs) and pre-osteoblasts. BTC-driven proliferation is dependent on hypoxia-inducible factor-alpha (HIF-alpha).
Area of Science:
- Cellular and Molecular Biology
- Bone Biology and Metabolism
- Stem Cell Biology
Background:
- Cellular signaling pathways, including those involving epidermal growth factor (EGF), regulate cell fate and behavior.
- Osteoblasts are crucial for bone formation and express EGF receptors, responding to EGF signaling by altering proliferation and differentiation.
- Previous studies showed increased cortical bone in mice overexpressing betacellulin (BTC), but the specific cell types involved were unclear.
Purpose of the Study:
- To investigate the specific effects of betacellulin (BTC) on the proliferation and differentiation of mesenchymal stem cells (MSCs) and pre-osteoblasts.
- To elucidate the role of hypoxia-inducible factor-alpha (HIF-alpha) in BTC-mediated cellular responses.
- To characterize the expression of EGF receptors (ErbBs) in MSCs and pre-osteoblasts during differentiation.
Main Methods:
- Treatment of MSCs and pre-osteoblasts with betacellulin (BTC).
- Assessment of osteogenic marker expression.
- Evaluation of proliferation rates, including experiments with a hypoxia-inducible factor-alpha (HIF-alpha) antagonist.
- Analysis of EGF receptor (ErbB1, ErbB2, ErbB3) expression levels.
Main Results:
- Betacellulin (BTC) significantly decreased the expression of osteogenic markers in both MSCs and pre-osteoblasts.
- BTC-induced proliferation in these cells was dependent on hypoxia-inducible factor-alpha (HIF-alpha), as its inhibition blocked the proliferative effect.
- MSCs and pre-osteoblasts consistently expressed EGF receptors ErbB1, ErbB2, and ErbB3, irrespective of osteogenic differentiation status.
Conclusions:
- Betacellulin (BTC) negatively influences osteogenic differentiation in mesenchymal stem cells and pre-osteoblasts.
- Hypoxia-inducible factor-alpha (HIF-alpha) is a critical mediator of betacellulin's proliferative effects on bone cells.
- These findings provide the first evidence of BTC's direct impact on MSCs and highlight the role of HIF-alpha in BTC-driven proliferation.
Related Concept Videos
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Cell Specific Gene Expression
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
